Literature DB >> 6982862

Modulation of mitogen-induced proliferation of autologous peripheral blood lymphocytes by human alveolar macrophages.

H Yeager, J A Sweeney, H B Herscowitz, I S Barsoum, E Kagan.   

Abstract

Experiments were carried out to determine the effect of cocultivation of T-cell-enriched human peripheral blood lymphocytes with autologous alveolar macrophages on mitogen-induced proliferation as determined by [(3)H]thymidine uptake. Cells obtained by fiberoptic bronchoscopy and saline bronchial lavage from 14 normal volunteers were enriched for macrophages by adherence in plastic dishes for 1 h in RPMI 1640 medium supplemented with 10% fetal calf serum. Nonadherent mononuclear cells were prepared from heparinized venous blood after Ficoll-Hypaque sedimentation by passage over nylon wool columns. T-cell-enriched populations were incubated with and without alveolar macrophages, either in the presence or absence of phytohemagglutinin. In these experiments, the number of lymphocytes was held constant (10(5) per well), while the number of alveolar macrophages was varied (0.1 x 10(5) to 4.0 x 10(5) per well). Alveolar macrophages generally tended to stimulate phytohemagglutinin-induced lymphoproliferation at lymphocyte/macrophage ratios of 10:1 but consistently and significantly suppressed proliferation at ratios which approach those usually observed in recovered human bronchial lavage fluid, namely, 1:4. The suppressive effect of alveolar macrophages was observed as early as 48 h after culture initiation, while the magnitude of suppression increased with time. Suppression did not appear to be due to alteration in lymphocyte viability, nor was it sensitive to indomethacin. These results indicate that human alveolar macrophages can modulate the in vitro proliferative response of autologous peripheral blood lymphocytes. This observation may have relevance to interactions between alveolar macrophages and bronchial lymphocytes in the human lung in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982862      PMCID: PMC347727          DOI: 10.1128/iai.38.1.260-266.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

2.  The proliferative response of bronchus-associated lymphoid tissue after local and systemic immunization.

Authors:  R Clancy; J Bienenstock
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Pinocytosis by human alveolar macrophages. Comparison of smokers and nonsmokers.

Authors:  H Yeager; S M Zimmet; S L Schwartz
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

5.  Peritoneal macrophages in the immune response to SRBC in vitro.

Authors:  M Hoffmann
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397

Review 6.  The J. Burns Amberson LECTURE The induction and expression of cell-mediated hypersensitivity in the lung.

Authors:  G B Mackaness
Journal:  Am Rev Respir Dis       Date:  1971-12

7.  A requirement for two cell types for antibody formation in vitro.

Authors:  D E Mosier
Journal:  Science       Date:  1967-12-22       Impact factor: 47.728

8.  Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers.

Authors:  J O Harris; E W Swenson; J E Johnson
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

9.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes.

Authors:  A S Rosenthal; E M Shevach
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

10.  Cellular interactions in the proliferative response of human T and B lymphocytes to phytomitogens and allogeneic lymphocytes.

Authors:  H P Lohrmann; L Novikovs; R G Graw
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Down-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophages.

Authors:  P G Holt
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

2.  An immunohistochemical study on phenotypic heterogeneity of human pulmonary vascular endothelial cells.

Authors:  M Yamamoto; K Shimokata; H Nagura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

3.  Pulmonary and systemic immunoregulatory changes during the development of experimental asbestosis.

Authors:  M Rola-Pleszczynski; S Gouin; R Bégin
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

Review 4.  Immunological control of tuberculosis: role of tumour necrosis factor and more.

Authors:  S Stenger
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

5.  Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans.

Authors:  Mark E Snyder; Anna Bondonese; Andrew Craig; Iulia Popescu; Matthew R Morrell; Michael M Myerburg; Carlo J Iasella; Elizabeth Lendermon; Joseph Pilweski; Bruce Johnson; Silpa Kilaru; Yingze Zhang; Humberto E Trejo Bittar; Xingan Wang; Pablo G Sanchez; Fadi Lakkis; John McDyer
Journal:  Am J Transplant       Date:  2021-09-07       Impact factor: 9.369

6.  Immunosuppressive activity induced by nitric oxide in culture supernatant of activated rat alveolar macrophages.

Authors:  T Kawabe; K I Isobe; Y Hasegawa; I Nakashima; K Shimokata
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

7.  Human bronchoalveolar macrophage heterogeneity demonstrated by histochemistry, surface markers and phagocytosis.

Authors:  V A Gant; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

8.  Modulation of macrophage suppressive activity and prostaglandin release by lymphokines and interferon: comparison of alveolar, pleural and peritoneal macrophages.

Authors:  P Sestini; A Tagliabue; D Boraschi
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

9.  Persistence of influenza as an immunogen in pulmonary antigen-presenting cells.

Authors:  M F Lipscomb; D Yeakel-Houlihan; C R Lyons; R R Gleason; J Stein-Streilein
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor.

Authors:  N Bilyk; P G Holt
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.